Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 33.3B | 30.4B | 33.7B | 35.5B |
Cost of revenue | 29.9B | 28.5B | 31.6B | 32.7B |
Gross profit | 3.4B | 2.0B | 2.1B | 2.8B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 582M | 519M | 511M | 1.2B |
Other operating expenses | 1.4B | 1.6B | 1.6B | 1.5B |
Operating income | 1.2B | -395M | -42M | 45M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 274M | 233M | 233M | 237M |
Other income expense | 204M | 1.3B | 104M | 605M |
Pretax income | 1.1B | 648M | -13M | 413M |
Tax provision | 212M | 122M | -38M | 44M |
Net income | 908M | 526M | 25M | 369M |
Basic EPS | 2.2 | 1.2 | 0.0 | 0.8 |
Diluted EPS | 2.2 | 1.2 | 0.0 | 0.8 |
Basic average shares | 406.8M | 409.2M | 411.7M | 417.3M |
Diluted average shares | 407.9M | 410.5M | 413.0M | 418.8M |
EBITDA | 2.3B | 605M | 948M | 1.2B |
Net income from continuing op. | 908M | 526M | 25M | 369M |
Minority interests | -31M | -39M | -17M | -23M |
Preferred stock dividends | 2M | 2M | 2M | 3M |